目前的实践中介风险差异化甲状腺癌 - - 综述
Rosalia do Prado Padovani1, Fernanda Barbosa Duarte2, Camila Nascimento3
1Section of Endocrinology and Metabolism, Department of Medicine, Faculdade de Ciências Médicas da Santa Casa de São Paulo, Rua Doutor Cesário Mota Junior, , 61 - SAO PAULO -CEP, São Paulo, 1221020, Brazil. rosaliapadovani@yahoo.com.br.
Reviews in endocrine & metabolic disorders
|November 23, 2023
概括
由于异质的复发风险,中等风险差异化甲状腺癌 (DTC) 的管理是复杂的. 这一概述有助于个性化辅助治疗决策,包括分子分析,以改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
- 分子诊断学 分子诊断
背景情况:
- 差异化甲状腺癌 (DTC) 通常有很好的预后,但有些患者面临复发或治疗阻力.
- 个性化管理策略越来越多地被采用,以优化有效性并最大限度地减少干预.
- 手术后风险分层对于指导辅助治疗和随访强度至关重要.
研究的目的:
- 审查中等风险的DTC,重点关注辅助治疗决策的标准.
- 突出分子分析在完善个性化患者管理中的作用.
- 解决中等风险DTC管理中的异质性和缺乏共识的问题.
主要方法:
- 对当前指南的文献综述和关于中等风险DTC的研究.
- 分析风险分层标准及其对辅助治疗建议的影响.
- 在中等风险的DTC中探索分子标记物的实用性.
主要成果:
- 中级风险的DTC是一个异质的群体,复发风险为5-20%,缺乏长期数据和辅助治疗的共识.
- 目前的指导方针建议风险分层,但为此中间组提供有限的具体指导.
- 分子分析显示,有可能提高风险评估和治疗决策的准确性.
结论:
- 个性化的方法对于中等风险的DTC是必不可少的,考虑到不同的临床和分子因素.
- 辅助治疗决策需要仔细考虑个体患者的个人资料,因为类别异质.
- 需要进一步的研究和共识,以优化中等风险DTC的管理.
相关概念视频
Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...


